Stock detail
Ionis Pharmaceuticals (IONS) stock price, chart, and key data
View Ionis Pharmaceuticals stock price, chart movement, and headline metrics on Woodstock's stock detail page.
Stock detail
Ionis Pharmaceuticals
IONS · XNAS
+$2.03 (+2.76%) past month
$75.58
After hours $78.02 (+3.23%)
Key metrics
Close price
$75.58
52-week range
$32.00 - $86.74
Market cap
$12.5B
About the company
IONIS PHARMACEUTICALS
Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, and rare diseases. Ionis and Biogen brought Spinraza to market in 2016 as a treatment for spinal muscular atrophy, and Biogen launched ALS drug Qalsody in 2023. Ionis brought two additional drugs to market via its cardiovascular-focused subsidiary Akcea, including ATTR amyloidosis drug Tegsedi (2018) and cardiology drug Waylivra (Europe, 2019). Ionis and AstraZeneca launched polyneuropathy drug Wainua in 2024. Ionis marked its first two independent launches in 2025 for Tryngolza (for FCS) and Dawnzera (for HAE).
24/5 Trading
Act on the stock when the timing works for you.
With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.
*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.
Download the app